Eli Lilly and Company (LLY · NYSE)
LLY · MARKET VIEW
Market view · as of Sep 14, 2026
Revenue (TTM)
$79.67B
+47.7% YoY
Gross margin
83.4%
EPS (latest q)
$8.38
vs $6.01 est · beat
52-wk position
71.1%
-12.9% vs 52w high · -7.6% 1mo
Price (last ~year)
Eli Lilly and Company (LLY) maintains a market capitalization of $994.92 billion, supported by 47.7% year-over-year revenue growth and four consecutive quarterly earnings beats. The company generated $79.67 billion in trailing twelve-month revenue, with a 33.5% profit margin and $7.76 billion in free cash flow as of June 30, 2026. Shares are currently priced at $1115.70, reflecting a 7.6% decline over the past month and an RSI of 2.
Valuation
- Market cap
- $994.92B
- P/E
- 37.45
- PEG
- 1.103
- P/B
- 29.35
- P/S
- 12.49
- EV/EBITDA
- 24.95
- Beta
- 0.502
- Analyst target
- $1318.66
Quality & returns
- Gross margin
- 83.4%
- Operating margin
- 54.2%
- Profit margin
- 33.5%
- ROE
- 102.3%
- ROA
- 20.4%
Price movement
- Last
- $1115.70
- 1-month
- -7.6%
- 3-month
- -0.5%
- RSI (14)
- 2
- vs SMA200
- +5.1%
- 52-wk position
- 71.1% -12.9% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $22.97B | $8.98B | $7.09B | $9.25B |
| 2026-03-31 | $19.80B | $8.85B | $7.40B | $9.69B |
| 2025-12-31 | $19.29B | $8.78B | $6.64B | $8.39B |
| 2025-09-30 | $17.60B | $8.39B | $5.58B | $7.88B |
Recent news
- Somewhat-Bearish Is Amgen (AMGN) Fully Valued As New IMDELLTRA Data Reshapes The Story? · 2026-09-13
- Somewhat-Bullish CVS Health Corporation $CVS Stake Increased by The Manufacturers Life Insurance Company · 2026-09-12
- Somewhat-Bullish The Manufacturers Life Insurance Company Sells 148,344 Shares of Gilead Sciences, Inc. $GILD · 2026-09-12
- Neutral Merck & Co., Inc. (NYSE:MRK) Lowered to Hold Rating by Wall Street Zen · 2026-09-12
- Somewhat-Bearish Novo Nordisk Stock (NVO) Falls After Morgan Stanley’s Sell Call on Market Share Loss to Eli Lilly, Patent Cliff · 2026-09-12
- Somewhat-Bullish Nuvectis at Cantor healthcare conference: betting on factor B · 2026-09-12
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)